Abstract
Functional outcomes are clinically important in the treatment of rectal cancer patients as they provide clinicians with important information to judge the patient’s status. Quality of life is based on the patient’s functional status; these two terms are often synonymous in healthcare. The function or quality of life is affected by rectal cancer itself and by its treatment. Clinicians must manage the patient’s quality of life and the patient’s concerns about disease symptoms and adverse effects. Because statistically significant differences in quality of life subscales may not be clinically important, it is critical to define what differences are clinically relevant. In addition, response shift phenomenon should be considered when interpreting quality of life in longitudinal studies. Although preoperative chemoradiotherapy has shifted the treatment paradigm toward organ preservation, its impact on quality of life is somewhat controversial when compared with no radiotherapy. Minimally invasive surgery may have clinical benefits on quality of life compared with open surgery, but no randomized controlled trials have demonstrated whether laparoscopic, robot-assisted, or transanal total mesorectal excision provides superior effects on quality of life. Sphincter-preserving surgery does not appear to be superior to a permanent stoma. Rectal cancer patients usually suffer from postoperative bowel dysfunction and sexual-urinary dysfunction, but we lack effective tools to preventive these dysfunctions. Therefore, patients should receive information about postoperative dysfunction before undergoing surgery. More work is needed to develop tools to prevent postoperative dysfunction related to rectal cancer treatment and to manage the quality of life of rectal cancer patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jorgensen ML, Young JM, Dobbins TA, Solomon MJ. Assessment of abdominoperineal resection rate as a surrogate marker of hospital quality in rectal cancer surgery. Br J Surg. 2013;100:1655–63.
Smith JJ, Garcia-Aguilar J. Advances and challenges in treatment of locally advanced rectal cancer. J Clin Oncol. 2015;33:1797–808.
Bryant CL, Lunniss PJ, Knowles CH, Thaha MA, Chan CL. Anterior resection syndrome. Lancet Oncol. 2012;13:e403–8.
Giandomenico F, Gavaruzzi T, Lotto L, et al. Quality of life after surgery for rectal cancer: a systematic review of comparisons with the general population. Exp Rev Gastroenterol Hepatol. 2015;9:1227–42.
Juul T, Thaysen H, Chen T. Quality of life in rectal cancer patients. In: Longo WE, Reddy V, Audisio RA, editors. Modern management of cancer of the rectum. London: Springer; 2015. p. 349–66.
Ho VP, Lee Y, Stein SL, Temple LK. Sexual function after treatment for rectal cancer: a review. Dis Colon Rectum. 2011;54:113–25.
Lundby L, Duelund-Jakobsen J. Management of fecal incontinence after treatment for rectal cancer. Curr Opin Support Palliat Care. 2011;5:60–4.
Martin ST, Heneghan HM, Winter DC. Systematic review of outcomes after intersphincteric resection for low rectal cancer. Br J Surg. 2012;99:603–12.
Saito N, Sugito M, Ito M, et al. Oncologic outcome of intersphincteric resection for very low rectal cancer. World J Surg. 2009;33:1750–6.
Schiessel R, Karner-Hanusch J, Herbst F, Teleky B, Wunderlich M. Intersphincteric resection for low rectal tumours. Br J Surg. 1994;81:1376–8.
van Duijvendijk P, Slors JF, Taat CW, et al. Prospective evaluation of anorectal function after total mesorectal excision for rectal carcinoma with or without preoperative radiotherapy. Am J Gastroenterol. 2002;97:2282–9.
Gotay CC. Assessing cancer-related quality of life across a spectrum of applications. J Natl Cancer Inst Monogr. 2004;2004:126–33.
Bottomley A. The cancer patient and quality of life. Oncologist. 2002;7:120–5.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.
Engel J, Kerr J, Schlesinger-Raab A, Eckel R, Sauer H, Hölzel D. Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg. 2003;238:203–13.
Neuman HB, Schrag D, Cabral C, et al. Can differences in bowel function after surgery for rectal cancer be identified by the European Organization for Research and Treatment of Cancer quality of life instrument? Ann Surg Oncol. 2007;14:1727–34.
Gujral S, Conroy T, Fleissner C, et al. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer. 2007;43:1564–73.
Yun YH, Park YS, Lee ES, et al. Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res. 2004;13:863–8.
Ihn MH, Lee SM, Son IT, et al. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer. Support Care Cancer. 2015;23:3493–501.
Fayers P, Aaronson N, Bjordal K, et al. The EORTC QLQ-C30 scoring manual. 3rd ed. Brussels: European Organisation for Research and Treatment of Cancer; 2001.
Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29:89–96.
Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11:637–45.
Nord E. The significance of contextual factors in valuing health states. Health Policy. 1989;13:189–98.
Gosselink MP, Busschbach JJ, Dijkhuis CM, Stassen LP, Hop WC, Schouten WR. Quality of life after total mesorectal excision for rectal cancer. Color Dis. 2006;8:15–22.
Sprangers MA. Response-shift bias: a challenge to the assessment of patients’ quality of life in cancer clinical trials. Cancer Treat Rev. 1996;22(Suppl A):55–62.
Schwartz CE, Sprangers MA. Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Soc Sci Med. 1999;48:1531–48.
Ziv Y, Zbar A, Bar-Shavit Y, Igov I. Low anterior resection syndrome (LARS): cause and effect and reconstructive considerations. Tech Coloproctol. 2013;17:151–62.
Chen TY, Wiltink LM, Nout RA, et al. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. Clin Colorectal Cancer. 2015;14:106–14.
Denost Q, Laurent C, Capdepont M, Zerbib F, Rullier E. Risk factors for fecal incontinence after intersphincteric resection for rectal cancer. Dis Colon Rectum. 2011;54:963–8.
Ihn MH, Kang SB, Kim DW, et al. Risk factors for bowel dysfunction after sphincter-preserving rectal cancer surgery: a prospective study using the Memorial Sloan Kettering Cancer Center bowel function instrument. Dis Colon Rectum. 2014;57:958–66.
O’Riordain MG, Molloy RG, Gillen P, Horgan A, Kirwan WO. Rectoanal inhibitory reflex following low stapled anterior resection of the rectum. Dis Colon Rectum. 1992;35:874–8.
Rao SS, Welcher KD, Leistikow JS. Obstructive defecation: a failure of rectoanal coordination. Am J Gastroenterol. 1998;93:1042–50.
Miller R, Bartolo DC, Cervero F, Mortensen NJ. Anorectal sampling: a comparison of normal and incontinent patients. Br J Surg. 1988;75:44–7.
Lee WY, Takahashi T, Pappas T, Mantyh CR, Ludwig KA. Surgical autonomic denervation results in altered colonic motility: an explanation for low anterior resection syndrome? Surgery. 2008;143:778–83.
Brown CJ, Fenech DS, McLeod RS. Reconstructive techniques after rectal resection for rectal cancer. Cochrane Database Syst Rev. 2008;16:CD006040. https://doi.org/10.1002/14651858.
Hüttner FJ, Tenckhoff S, Jensen K, Uhlmann L, Kulu Y, Büchler MW, Diener MK, Ulrich A. Meta-analysis of reconstruction techniques after low anterior resection for rectal cancer. Br J Surg. 2015;102:735–45.
Park JG, Lee MR, Lim SB, et al. Colonic J-pouch anal anastomosis after ultralow anterior resection with upper sphincter excision for low-lying rectal cancer. World J Gastroenterol. 2005;11:2570–3.
Celentano V, Cohen R, Warusavitarne J, Faiz O, Chand M. Sexual dysfunction following rectal cancer surgery. Int J Color Dis. 2017. https://doi.org/10.1007/s00384-017-2826-4.
da Silva GM, Hull T, Roberts PL, et al. The effect of colorectal surgery in female sexual function, body image, self-esteem and general health: a prospective study. Ann Surg. 2008;248:266–72.
Sanoff HK, Morris W, Mitcheltree AL, Wilson S, Lund JL. Lack of support and information regarding long-term negative effects in survivors of rectal cancer. Clin J Oncol Nurs. 2015;19:444–8.
Leon-Carlyle M, Schmocker S, Victor JC, et al. Prevalence of physiologic sexual dysfunction is high following treatment for rectal cancer: but is it the only thing that matters? Dis Colon Rectum. 2015;58:736–42.
Chorost MI, Weber TK, RJ LEE, Rodriguez-Bigas MA, Petrelli NJ. Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg. 2000;179:271–4.
Hendren SK, O’Connor BI, Liu M, et al. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg. 2005;242:212–23.
Angenete E, Asplund D, Andersson J, Haglind E. Self reported experience of sexual function and quality after abdominoperineal excision in a prospective cohort. Int J Surg. 2014;12:1221–7.
Duran E, Tanriseven M, Ersoz N, et al. Urinary and sexual dysfunction rates and risk factors following rectal cancer surgery. Int J Color Dis. 2015;30:1547–55.
Lee SY, Kang SB, Kim DW, HK O, Ihn MH. Risk factors and preventive measures for acute urinary retention after rectal cancer surgery. World J Surg. 2015;39:275–82.
Jang JH, Kang SB, Lee SM, Park JS, Kim DW, Ahn S. Randomized controlled trial of tamsulosin for prevention of acute voiding difficulty after rectal cancer surgery. World J Surg. 2012;36:2730–7.
Wiltink LM, Chen TY, Nout RA, et al. Health-related quality of life 14 years after preoperative short-term radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomised trial. Eur J Cancer. 2014;50:2390–8.
Huang M, Lin J, Yu X, et al. Erectile and urinary function in men with rectal cancer treated by neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy alone: a randomized trial report. Int J Color Dis. 2016;31:1349–57.
De Caluwé L, Van Nieuwenhove Y, Ceelen WP. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev. 2013;28:CD006041. https://doi.org/10.1002/14651858.CD006041.pub3.
Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA. 2015;314:1346–55.
Stevenson AR, Solomon MJ, Lumley JW, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA. 2015;314:1356–63.
Andersson J, Angenete E, Gellerstedt M, et al. Health-related quality of life after laparoscopic and open surgery for rectal cancer in a randomized trial. Br J Surg. 2013;100:941–9.
Lim RS, Yang TX, Chua TC. Postoperative bladder and sexual function in patients undergoing surgery for rectal cancer: a systematic review and meta-analysis of laparoscopic versus open resection of rectal cancer. Tech Coloproctol. 2014;18:993–1002.
Panteleimonitis S, Ahmed J, Harper M, Parvaiz A. Critical analysis of the literature investigating urogenital function preservation following robotic rectal cancer surgery. World J Gastrointest Surg. 2016;8:744–54.
Broholm M, Pommergaard HC, Gögenür I. Possible benefits of robot-assisted rectal cancer surgery regarding urological and sexual dysfunction: a systematic review and meta-analysis. Color Dis. 2015;17:375–81.
Pontallier A, Denost Q, Van Geluwe B, Adam JP, Celerier B, Rullier E. Potential sexual function improvement by using transanal mesorectal approach for laparoscopic low rectal cancer excision. Surg Endosc. 2016;30:4924–33.
Sideris L, Zenasni F, Vernerey D, et al. Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients’ characteristics. Dis Colon Rectum. 2005;48:2180–91.
Temple LK, Romanus D, Niland J, et al. Factors associated with sphincter-preserving surgery for rectal cancer at national comprehensive cancer network centers. Ann Surg. 2009;250:260–7.
Morris E, Quirke P, Thomas JD, Fairley L, Cottier B, Forman D. Unacceptable variation in abdominoperineal excision rates for rectal cancer: time to intervene? Gut. 2008;57:1690–7.
Lim SB, Heo SC, Lee MR, et al. Changes in outcome with sphincter preserving surgery for rectal cancer in Korea, 1991-2000. Eur J Surg Oncol. 2005;31:242–9.
Tilney HS, Heriot AG, Purkayastha S, et al. A national perspective on the decline of abdominoperineal resection for rectal cancer. Ann Surg. 2008;247:77–84.
Russell MM, Ganz PA, Lopa S, et al. Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04. Ann Surg. 2015;261:144–8.
Monastyrska E, Hagner W, Jankowski M, Głowacka I, Zegarska B, Zegarski W. Prospective assessment of the quality of life in patients treated surgically for rectal cancer with lower anterior resection and abdominoperineal resection. Eur J Surg Oncol. 2016;42:1647–53.
Näsvall P, Dahlstrand U, Löwenmark T, Rutegård J, Gunnarsson U, Strigård K. Quality of life in patients with a permanent stoma after rectal cancer surgery. Qual Life Res. 2017;26:55–64.
How P, Stelzner S, Branagan G, et al. Comparative quality of life in patients following abdominoperineal excision and low anterior resection for low rectal cancer. Dis Colon Rectum. 2012;55:400–6.
Kasparek MS, Hassan I, Cima RR, Larson DR, Gullerud RE, Wolff BG. Quality of life after coloanal anastomosis and abdominoperineal resection for distal rectal cancers: sphincter preservation vs quality of life. Color Dis. 2011;13:872–7.
Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. 2005;18:CD004323.
Disclosure
The author has no potential conflicts of interest to declare. The author received no commercial support for this study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kang, SB., Kang, S.I. (2018). Functional Outcomes in Rectal Cancer Patients After Surgical Treatment. In: Kim, N., Sugihara, K., Liang, JT. (eds) Surgical Treatment of Colorectal Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-10-5143-2_19
Download citation
DOI: https://doi.org/10.1007/978-981-10-5143-2_19
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5142-5
Online ISBN: 978-981-10-5143-2
eBook Packages: MedicineMedicine (R0)